Influenza Diagnostics Market By Type (RT-PCR, Viral Culture, Antigen Detection Tests, Serological Assays, Simple Amplification-based Assays, Molecular Assays, and Others) By End-Users (Hospitals, Clinics, Diagnostic Laboratories and Others) and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI497722 | Publish Date: February 2024 | No. of Pages: 170

Influenza Diagnostics Market Companies

  • Genes2Me
  • 3M Company
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • F. Hoffman-LA Roche AG
  • Becton Dickinson and Company
  • Quidel Corporation
  • Virax BioLabs
  • Luminex Corporation
  • Hologic

Recent News:

  • The first "Made in India" RT-PCR kit, called "CovFlu," was introduced by Genes2Me in May 2022. It is designed to detect and classify COVID-19, influenza A, and influenza B viruses in under 50 minutes. A recently released kit correctly detects SARS-CoV-2 and influenza A and B viruses. According to the ICMR-approved validation center report, "CovFlu" has been approved by DCGI and has been found to have 100% specificity and sensitivity. The recently introduced kit is affordable and provided to public and private labs.
  • Virax Biolabs released a new RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit in Europe in November 2022. With availability, a recently released kit can be used for accurate diagnosis of influenza, respiratory syncytial virus (RSV), and COVID-19 virus infections at home and in point-of-care settings.